IINN vs. CTSO, CTCX, PYPD, MDAI, DXR, SRTS, EDAP, ZYXI, APT, and SURG
Should you be buying Inspira Technologies OXY B.H.N. stock or one of its competitors? The main competitors of Inspira Technologies OXY B.H.N. include Cytosorbents (CTSO), Carmell (CTCX), PolyPid (PYPD), Spectral AI (MDAI), Daxor (DXR), Sensus Healthcare (SRTS), EDAP TMS (EDAP), Zynex (ZYXI), Alpha Pro Tech (APT), and SurgePays (SURG). These companies are all part of the "medical equipment" industry.
Inspira Technologies OXY B.H.N. vs. Its Competitors
Inspira Technologies OXY B.H.N. (NASDAQ:IINN) and Cytosorbents (NASDAQ:CTSO) are both small-cap medical companies, but which is the superior business? We will contrast the two businesses based on the strength of their risk, earnings, analyst recommendations, media sentiment, valuation, profitability, dividends and institutional ownership.
Inspira Technologies OXY B.H.N. has higher earnings, but lower revenue than Cytosorbents.
Inspira Technologies OXY B.H.N. has a beta of 2.28, suggesting that its stock price is 128% more volatile than the S&P 500. Comparatively, Cytosorbents has a beta of 1.28, suggesting that its stock price is 28% more volatile than the S&P 500.
Inspira Technologies OXY B.H.N. currently has a consensus target price of $2.00, indicating a potential upside of 76.99%. Cytosorbents has a consensus target price of $5.50, indicating a potential upside of 463.81%. Given Cytosorbents' higher possible upside, analysts plainly believe Cytosorbents is more favorable than Inspira Technologies OXY B.H.N..
12.7% of Inspira Technologies OXY B.H.N. shares are held by institutional investors. Comparatively, 32.9% of Cytosorbents shares are held by institutional investors. 29.4% of Inspira Technologies OXY B.H.N. shares are held by insiders. Comparatively, 7.3% of Cytosorbents shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Inspira Technologies OXY B.H.N. has a net margin of 0.00% compared to Cytosorbents' net margin of -25.58%. Inspira Technologies OXY B.H.N.'s return on equity of 0.00% beat Cytosorbents' return on equity.
In the previous week, Inspira Technologies OXY B.H.N. had 2 more articles in the media than Cytosorbents. MarketBeat recorded 3 mentions for Inspira Technologies OXY B.H.N. and 1 mentions for Cytosorbents. Cytosorbents' average media sentiment score of 1.54 beat Inspira Technologies OXY B.H.N.'s score of 1.06 indicating that Cytosorbents is being referred to more favorably in the news media.
Summary
Inspira Technologies OXY B.H.N. beats Cytosorbents on 8 of the 12 factors compared between the two stocks.
Get Inspira Technologies OXY B.H.N. News Delivered to You Automatically
Sign up to receive the latest news and ratings for IINN and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding IINN and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Inspira Technologies OXY B.H.N. Competitors List
Related Companies and Tools
This page (NASDAQ:IINN) was last updated on 9/4/2025 by MarketBeat.com Staff
Free IINN Stock Alerts